4461 - 4470 of 7915 Results
Title
Year
-
RESTRICTEDTitle: Missing heritability in Parkinson’s disease: the emerging role of non-coding genetic variationJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 127Issue #: 5Start Page: 729End Page: 748Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00702-020-02184-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-020-02184-0.pdfCitation Count: 28
-
RESTRICTEDTitle: Advantages and Recent Developments of Autologous Cell Therapy for Parkinson’s Disease PatientsJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2020.00058Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2020.00058/pdfCitation Count: 28
- Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson’s Disease in the Harvard Biomarkers Study2020OPENTitle: Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson’s Disease in the Harvard Biomarkers StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 505End Page: 510Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-191882Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416447Citation Count: 36
- Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion2020OPENTitle: Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusionJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 7Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000000711Best OA location URL: https://nn.neurology.org/content/nnn/7/3/e711.full.pdfCitation Count: 10
- Combined mGlu2 orthosteric stimulation and positive allosteric modulation alleviates l-DOPA-induced psychosis-like behaviours and dyskinesia in the parkinsonian marmoset2020RESTRICTEDTitle: Combined mGlu2 orthosteric stimulation and positive allosteric modulation alleviates l-DOPA-induced psychosis-like behaviours and dyskinesia in the parkinsonian marmosetJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 127Issue #: 7Start Page: 1023End Page: 1029Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-020-02185-zCitation Count: 10
- Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson’s Disease?2020RESTRICTEDTitle: Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson’s Disease?Journal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 10Issue #: 2Start Page: 405End Page: 411Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191877Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191877?id=journal-of-parkinsons-disease%2Fjpd191877Citation Count: 19
- EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s Disease2020OPENTitle: EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 543End Page: 558Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191841Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191841?id=journal-of-parkinsons-disease%2Fjpd191841Citation Count: 23
- Impact of depressive symptoms on self-perceived severity of autonomic dysfunction in multiple system atrophy: relevance for patient-reported outcomes in clinical trials2020OPENTitle: Impact of depressive symptoms on self-perceived severity of autonomic dysfunction in multiple system atrophy: relevance for patient-reported outcomes in clinical trialsJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 3Start Page: 215End Page: 221Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-020-00681-6Best OA location URL: https://europepmc.org/articles/pmc7341538?pdf=renderCitation Count: 12
- Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson’s Disease Research: The Fox Insight Cohort Experience2020OPENTitle: Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson’s Disease Research: The Fox Insight Cohort ExperienceJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 665End Page: 675Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-191901Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191901?id=journal-of-parkinsons-disease%2Fjpd191901Citation Count: 42
- Substantia Nigra Volume Dissociates Bradykinesia and Rigidity from Tremor in Parkinson’s Disease: A 7 Tesla Imaging Study2020OPENTitle: Substantia Nigra Volume Dissociates Bradykinesia and Rigidity from Tremor in Parkinson’s Disease: A 7 Tesla Imaging StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 591End Page: 604Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191890Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191890?id=journal-of-parkinsons-disease%2Fjpd191890Citation Count: 24